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Abstract
Air pollution continues to be a key health issue in Scotland, despite recent
improvements in concentrations. The Scottish Government published the
Cleaner Air For Scotland strategy in 2015, and will introduce Low Emis-
sion Zones (LEZs) in the four major cities (Aberdeen, Dundee, Edinburgh
and Glasgow) by 2020. However, there is no epidemiological evidence quan-
tifying the current health impact of air pollution in Scotland, which this
paper addresses. Additionally, we estimate the health benefits of reducing
concentrations in city centres where most LEZs are located. We focus on
cardio-respiratory disease and total non-accidental mortality outcomes, link-
ing them to concentrations of both particulate (PM10 and PM2.5) and gaseous
(NO2 and NOx) pollutants. Our two main findings are that: (i) all pollutants
exhibit significant associations with respiratory disease but not cardiovascu-
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lar disease; and (ii) reducing concentrations in city centres with low resident
populations only provides a small health benefit.
Keywords: Air pollution, Cardio-respiratory disease, Epidemiological
modelling
1. Introduction1
Air pollution is the biggest environmental risk to health across the world,2
with the World Health Organisation (WHO) estimating that 3 million deaths3
are attributable to it each year (World Health Organisation, 2016). Pollution4
concentrations around the world often exceed safe levels, with an estimated5
90% of the population living in areas where pollutants exceed WHO guideline6
levels (also World Health Organisation, 2016). The true impact on health7
is difficult to measure directly, and estimates vary with wide uncertainty8
intervals. The United Kingdom (UK) Royal College of Physicians estimated9
that up to 40,000 deaths in the UK could be attributable to air pollution10
each year (Royal College of Physicians, 2016).11
The focus of this study is Scotland, UK, where pollution concentra-12
tions are now comparatively low, although there are 39 declared Air Qual-13
ity Management Areas (AQMA, http://www.scottishairquality.co.uk/14
laqm/aqma), which either breach or are likely to breach legal pollution limits15
set by the European Union (EU, European Parliament, 2008). The majority16
of these breaches are for nitrogen dioxide (NO2, 27 areas) and / or coarse17
particulate matter (PM10, 24 areas), with only one for sulphur dioxide (SO2).18
The Scottish Government published the Cleaner Air For Scotland (CAFS)19
strategy (http://www.gov.scot/Resource/0048/00488493.pdf) in 2015,20
2
Figure 1: Boundary of Glasgow City Councils Air Quality Management Area, which is
the location for the proposed LEZ.
which proposes interventions directed particularly at reducing traffic related21
pollution. One such intervention is a Low Emission Zone (LEZ), where ve-22
hicles that do not meet specified emission standards are banned from, or23
attract fines for, entering the zone. The first LEZ in Scotland was intro-24
duced in the city of Glasgow at the end of 2018 (https://news.gov.scot/25
news/first-low-emission-zone-for-glasgow), with a phased implemen-26
tation over 5 years starting with buses that do not meet the EURO 6 emission27
standard. The other 3 main cities (Aberdeen, Dundee and Edinburgh) are28
mandated by the Scottish Government to follow suit by the end of 2020.29
The location for the Glasgow LEZ is the city centre (see Figure 1), bounded30
by the M8 motorway (west and north), river Clyde (south) and High street31
(east).32
The city centre has been specified for the LEZ because it was identified as33
the area most likely to exceed EU limit values for NO2 through the assessment34
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of air quality data. For example, despite the continual improvements in mea-35
sured NO2, the Glasgow Kerbside monitoring station (in the city centre) con-36
tinually exceeds the EU limit of 40µg m−3 for annual mean NO2, with many of37
the passive diffusion tube sites within the city centre AQMA also continuing38
to exceed this limit (see http://www.scottishairquality.co.uk/assets/39
documents//Glasgow_LAQM_Annual_Progress_Report_2017.pdf). Thus as40
the Glasgow LEZ was located based on achieving regulatory compliance, the41
improvement of public health was not the primary driver in deciding the42
location. Possible public health drivers for an air pollution intervention in-43
clude the reduction of the overall risk from air pollution, and a reduction44
in the number of disease cases, the latter being naturally targeted at highly45
populated and high risk areas.46
For the Glasgow LEZ, its beneficial health impact will depend on the size,47
demographics and underlying health of the population who spend time in the48
LEZ, as well as on the scale of reduction in pollution concentrations that it49
achieves. Thus while the city centre has the highest pollution concentrations50
within the city, it also has a very low resident population and thus may have51
a limited impact on the majority of Glasgow’s population. This preceding52
argument however does not account for people who travel into the city centre53
for work or pleasure for large periods of time, which illustrates the complexity54
of comprehensively evaluating the health impact of an LEZ.55
Our aims for this paper are two-fold, with the first being to provide up-56
to-date policy relevant evidence about the impact of long-term exposure to57
coarse and fine particulate matter (PM10 and PM2.5) and oxides of nitrogen58
(NO2 and NOx) on a range of health outcomes to address the gap in the59
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evidence base about the health impacts of current levels of air pollution60
concentrations in Scotland. Existing studies include Lee et al. (2009); Lee61
(2012); Willocks et al. (2012); Dibben and Clemens (2015) and Huang et al.62
(2015), but are based on relatively old data up to 2011. Our second aim is63
to use our modelling results to estimate the spatially-varying health benefits64
of reducing air pollution concentrations in Scotland’s cities, specifically in65
city centres where LEZs are most likely to be located. The data and study66
region are presented in Section 2, while the proposed statistical methodology67
is outlined in Section 3. The results of the study are presented in Section 4,68
while a note of caution about comparing the results here to other studies is69
presented in Section 5. Finally, the key conclusions are presented in Section70
6.71
2. Data and study design72
The study is based in mainland Scotland for the two-year period 2015-73
2016, and the study region has been spatially partitioned into K = 125274
Intermediate Zones (IZ) that have an average population of around 4,000.75
The health effects associated with air pollution are estimated from the spatial76
contrasts in population-level disease incidence and air pollution concentra-77
tions across the study region, after adjusting for population demographics78
and socio-economic deprivation.79
2.1. Disease data80
The data are counts of the numbers of disease events from the populations81
living in each IZ in the two-year study period, and we consider the follow-82
ing 5 outcomes: respiratory hospitalisations and mortalities (ICD-10 codes83
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J00-J99), cardiovascular hospitalisations and mortalities (ICD-10 codes I00-84
I99), and total non-accidental mortalities. For the hospitalisation outcomes85
the data relate to the total numbers of events rather than the number of86
first events, so that an individual who has multiple hospitalisation events87
within the two-year period will contribute more than one event to the count88
data. All of these outcomes have been associated with air pollution in the89
existing literature (see Schwartz et al., 2001; Brook et al., 2004 and Lee90
et al., 2009), and cardiovascular and respiratory disease are two of Scotland’s91
leading causes of deaths (see http://www.gov.scot/Topics/Statistics/92
Browse/Health/TrendMortalityRates). These data are summarised in Ta-93
ble 1, where the figure for 0% represents the minimum number of counts94
recorded for the health outcome in any of the IZs and 100% of the distribu-95
tion represents the maximum count recorded among all the IZs.96
The area level disease counts depend on the size and age-sex structure of97
the population at risk within each areal unit (IZ), which is accounted for by98
computing the expected number of disease events in each IZ using indirect99
standardisation. Specifically, the population living within each IZ is split100
into strata based on 5-year age bands and sex, and the number of people in101
each strata is multiplied by national strata specific disease rates, which are102
then summed over strata to compute the expected count. Letting (Yk, ek)103
respectively denote the observed and expected numbers of disease events104
in the kth IZ, an exploratory measure of disease risk is the Standardised105
Morbidity / Mortality Ratio (SMR), which is computed as SMRk = Yk/ek.106
An SMR of one corresponds to an average risk area, while an SMR of 1.2107
corresponds to a 20% increased risk of disease compared to the Scottish108
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average.109
The spatial distribution of the SMR is summarised in Table 1, which110
shows that the average SMR is close to 1 in all cases, and that generally111
the mortality outcomes have a wider range of SMR values than the hospi-112
talisation outcomes due to the mortality outcomes having smaller numbers113
of incidents and hence being a more unstable ratio. The spatial pattern in114
the SMR for respiratory hospitalisations is displayed in panel A of Figure 2,115
which shows that the majority of the IZs are in the heavily populated central116
belt of Scotland containing the two largest cities Glasgow and Edinburgh. A117
large number of the high SMRs (dark colours) are in the city of Glasgow,118
which is known to exhibit some of the worst health in the United Kingdom119
(Walsh et al., 2017). The SMRs for the remaining disease outcomes exhibit120
similar spatial patterns, with correlations ranging between 0.48 (between car-121
diovascular and respiratory mortality) and 0.77 (between cardiovascular and122
total non-accidental mortality).123
2.2. Air pollution data124
The network of air pollution monitors and diffusion tubes is relatively125
sparse in Scotland (see http://www.scottishairquality.co.uk), and is126
not sufficient for the small-area scale of this study. Therefore in common127
with Haining et al. (2010) and Lee et al. (2009) we utilise modelled concen-128
trations instead, specifically annual averages for 2015 and 2016 from the Pol-129
lution Climate Mapping (PCM) model (https://uk-air.defra.gov.uk/130
data/pcm-data) developed for the Department for the Environment, Food131
and Rural Affairs (DEFRA). This model estimates concentrations on a 1km132
square grid, which are spatially misaligned with the irregularly shaped Inter-133
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Table 1: Summary of the spatial distribution of the disease and pollution data across the
1252 Intermediate Zones.
Variable
Percentiles of the distribution
0% 25% 50% 75% 100%
Disease incidents (total counts)
Cardiovascular hospitalisation 26 101 131 166 354
Cardiovascular mortality 2 16 22 30 90
Respiratory hospitalisation 34 108 148 200 530
Respiratory mortality 0 7 11 15 50
Total non-accidental mortality 7 63 84 109 303
Disease risk (SMR)
Cardiovascular hospitalisation 0.44 0.83 0.98 1.17 2.16
Cardiovascular mortality 0.19 0.80 0.99 1.20 2.76
Respiratory hospitalisation 0.33 0.75 1.00 1.32 2.48
Respiratory mortality 0.00 0.67 0.96 1.31 3.44
Total non-accidental mortality 0.28 0.82 0.99 1.18 2.27
Air pollutants (in µg m−3)
NO2 1.3 5.8 9.8 14.0 38.3
NOx 1.7 7.6 13.3 19.8 74.7
PM2.5 3.2 5.6 6.1 6.5 9.1
PM10 5.5 9.0 10.0 10.8 13.9
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mediate Zones that the disease data relate to. Such spatial misalignment is134
often addressed by simple averaging (see Haining et al., 2010), which is the135
approach adopted here. Specifically, each 1km grid square has an associated136
centroid (central point), and the estimated pollution concentration for an137
IZ is the mean of the grid square concentrations whose centroids lie within138
the IZ. Any IZ that does not contain a grid square centroid is assigned the139
pollution concentration from the nearest grid square.140
In this study we consider concentrations of nitrogen dioxide (NO2), nitro-141
gen oxides (NOx), and coarse (PM10) and fine (PM2.5) particulate matter, all142
of which are measured in µg m−3. These pollutants are chosen because they143
are the ones responsible for all but one of Scotland’s air quality management144
areas. The spatial distribution of PM2.5 is displayed in panel B of Figure145
2, which shows it is highest in the cities of Glasgow and Edinburgh as well146
as around the east and south east coasts, the latter due to transboundary147
pollution from continental Europe and England respectively.148
A summary of the spatial distributions of all 4 pollutants is displayed149
in Table 1, which shows that the 2-year annual average concentrations are150
generally low. They also exhibit relatively little variation, with standard151
deviations of 5.5 (NO2), 8.8 (NOx), 0.8 (PM2.5) and 1.4 (PM10) respectively.152
Thus presenting the estimated PM10-disease associations as relative risks for a153
10µg m−3 increase in concentrations, as is done in existing time series studies154
(see Dominici et al., 2004), would not be sensible, because 10µg m−3 does155
not represent a plausible increase given the data. Therefore in the results we156
specify relative risks based on a 5µg m−3 increase for NO2 and NOx, and a157
1µg m−3 increase for PM2.5 and PM10, although we accept this is, as it has158
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to be, a somewhat arbitrary choice. Finally, the four pollutants are highly159
correlated spatially, with correlations of: 0.99 between NOx and NO2; 0.98160
between PM10 and PM2.5; and between 0.66 and 0.69 for all other pairs of161
pollutants.162
2.3. Confounder data163
One of the main factors affecting cardio-respiratory disease incidence is164
smoking (Hawthorne and Fry, 1978), and therefore areas with higher smok-165
ing prevalences are likely to exhibit higher numbers of disease incidents.166
However smoking prevalence data are unavailable at the IZ scale, but Klein-167
schmidt et al. (1995) have shown a strong link between smoking rates and168
socio-economic deprivation. Therefore we use the Scottish Index of Multi-169
ple Deprivation (SIMD, http://www.gov.scot/Topics/Statistics/SIMD)170
in our models as a proxy for smoking. The SIMD is a composite index con-171
sisting of deprivation indicators in the domains of access to services, crime,172
education, employment, health, housing and income, which are weighted and173
combined to create the final index.174
However, as the health domain in this overall index contains similar vari-175
ables to the disease outcome variables, it cannot be used as a covariate in176
the models. Therefore in the modelling described in Section 4 we consider177
the indicators for the 6 individual domains, excluding health, as possible co-178
variates. The crime indicator has a single IZ with a missing value, which is179
imputed by computing the average value from geographically neighbouring180
areas (those sharing a common border). Naturally however these six indi-181
cators are highly correlated, with the highest correlation being between the182
income and employment domains (correlation of 0.98), which thus means183
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Figure 2: Display of the data. The left panel (A) shows the standardised morbidity ratio
for respiratory hospitalisations, while the right panel (B) presents the average concentra-
tions of PM2.5.
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we do not include them in the same model. Finally, we also have the aver-184
age number of dwellings per hectare, which is a proxy measure of property185
density and hence urbanicity.186
2.4. Assessment of residual spatial autocorrelation187
Here we examine whether the disease outcomes contain residual spatial188
autocorrelation after covariate adjustment, because this will affect the choice189
of model that is appropriate for these data. To assess the presence or ab-190
sence of such correlation, overdispersed quasi-Poisson log-linear models were191
fitted to each disease outcome separately, where the expected disease counts192
ek were included as an offset term. The covariates included in the models193
were selected from the set described in the previous section, where the se-194
lection was based on the significance (at the 5% level) of their association195
with the disease outcomes and their pairwise correlations. The residuals196
from these models contained substantial overdispersion, with the estimated197
overdispersion parameter ωˆ (where Var[Yk] = ωE[Yk]) ranging between 1.35198
and 6.41 across the 5 disease outcomes. The residuals also contained substan-199
tial spatial autocorrelation, which was assessed by performing permutation200
tests based on Moran’s I statistic (Moran, 1950). The Moran’s I statistics201
ranged between 0.04 and 0.38 and had p-values less than 0.01 in all cases,202
which suggests that spatially correlated random effects that also account for203
overdispersion should be included in the final model.204
However, the residual surfaces do not vary smoothly in space, and instead205
exhibit subregions of spatial smoothness separated by abrupt step changes.206
This is illustrated in Section 1 of the supplementary material, which displays207
maps of the residuals from the model applied to the respiratory hospitali-208
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sations data zoomed in to the cities of Glasgow and Edinburgh. The maps209
show that while most pairs of spatially neighbouring IZs exhibit similar resid-210
ual values suggesting spatial autocorrelation, there are numerous examples211
of large step-changes between spatially neighbouring IZs. This suggests that212
a globally smooth spatial autocorrelation structure is unlikely to be appro-213
priate for these data, which motivates the use of the locally adaptive spatial214
smoothing model described in the next section.215
3. Methodology216
We quantify the impact of air pollution on disease risk using the spa-217
tial hierarchical regression model proposed by Lee and Mitchell (2013), be-218
cause it allows for localised spatial autocorrelation that is present between219
some pairs of neighbouring areas but absent between other pairs. Infer-220
ence is undertaken in a Bayesian paradigm using Integrated Nested Laplace221
Approximations (INLAs, Rue et al., 2009), utilising the R package INLA222
(http://www.r-inla.org). The overall model is presented in Section 3.1,223
while the iterative estimation algorithm is presented in Section 3.2. The224
model is fitted separately for each disease outcome, because this ensures225
that the cross correlations between the disease outcomes do not affect the226
estimated pollution-health relationships.227
3.1. Overall model228
Recall that (Yk, ek) respectively denote the observed and expected num-229
bers of disease events in IZ k for k = 1, . . . , K, while xk denotes the concen-230
tration of a single pollutant and zk = (1, zk1, . . . , zkp) denotes a vector of p231
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confounders including an intercept term. The data likelihood model is given232
by233
Yk ∼ Poisson(ekθk) for k = 1, . . . , K (1)
ln(θk) = z
>
kα + xkβ + φk,
where θk is the risk of disease relative to ek and can be interpreted on234
the same scale as the SMR. The regression parameters corresponding to235
each confounder (α = (α1, . . . , αp)) and the air pollution covariate (β) are236
assigned independent weakly informative Gaussian prior distributions, with237
a mean of zero and a variance of 100,000. The remaining term in the linear238
predictor is a set of random effects φ = (φ1, . . . , φK), which account for the239
residual overdispersion and spatial autocorrelation in the disease data not240
captured by the covariates. The spatial structure of the K IZs is quantified241
by a non-negative symmetric K ×K neighbourhood matrix W, and here we242
use the common binary specification where wki = 1 if areas (k, i) share a243
common border (denoted k ∼ i) and wki = 0 otherwise (also wkk = 0 ∀k).244
Then based on W we model φ using the conditional autoregressive (CAR)245
prior proposed by Leroux et al. (2000):246
φk|φ−k,W, τ 2, ρ ∼ N
(
ρ
∑K
i=1wkiφi
ρ
∑K
i=1wki + 1− ρ
,
τ 2
ρ
∑K
i=1wki + 1− ρ
)
(2)
τ 2 ∼ Inverse-gamma(1, 0.01)
ρ ∼ Uniform(0, 1),
where φ−k denotes the vector of random effects except φk. The prior mean247
of φk is a weighted average of the random effects φi in neighbouring areas248
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(those for which wki = 1), which thus induces spatial autocorrelation into φ.249
The strength of this spatial autocorrelation is controlled by ρ, where ρ = 1250
corresponds to strong spatial autocorrelation and simplifies to the intrinsic251
CAR model of Besag et al. (1991), while ρ = 0 corresponds to independence252
(φk ∼ N(0, τ 2)). However, model (2) enforces the random effects to exhibit253
a single global level of spatial smoothness controlled by ρ, which can be seen254
from its implied partial autocorrelations:255
Corr[φk, φi|φ−ki] =
ρwki√
(ρ
∑K
j=1wkj + 1− ρ)(ρ
∑K
j=1wij + 1− ρ)
. (3)
Thus if ρ is close to one then all pairs of random effects in neighbouring256
areas where wki = 1 will be partially autocorrelated, whilst if ρ is zero then257
they will all be independent. However, the exploratory analysis showed that258
such global spatial smoothness is inappropriate for our data, because some259
pairs of neighbouring areas have very similar values, suggesting ρ should260
be close to one, whilst other neighbouring pairs have very different values,261
suggesting ρ should be close to zero.262
Therefore we take the approach of Lee and Mitchell (2013) and estimate263
each element in the set {wki|k ∼ i} as 0 or 1, rather than assuming it is fixed264
equal to 1. Equation (3) shows that if wki = 1 then (φk, φi) will be modelled265
as partially autocorrelated and hence smoothed over in the modelling, while266
if wki = 0 then (φk, φi) are modelled as conditionally independent and no267
such spatial smoothing will be enforced. This potentially allows for isolated268
islands of correlation, where an area is not correlated to any of its neighbours.269
The major challenge when estimating {wki|k ∼ i} is overparameterisation,270
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because there are K = 1252 data points and 3281 neighbourhood elements271
{wki|k ∼ i} to be estimated. Therefore we update {wki|k ∼ i} determin-272
istically based on the remaining model parameters Θ = (α, β,φ, τ 2, ρ) in273
an iterative algorithm, rather than assigning each wki parameter a Bernoulli274
prior distribution. The algorithm proposed by Lee and Mitchell (2013) and275
used here is outlined below.276
3.2. Iterative estimation algorithm277
The algorithm iterates between updating: (i) Θ|W and (ii) W|Θ until278
convergence of W as follows.279
Estimation Algorithm280
1: Estimate a starting posterior distribution for Θ, by fitting model (1)-281
(2) based on the assumption that the random effects are independent282
(ρ = 0).283
2: Iterate the following two steps for j = 1, 2, . . . , j∗, until one of the two284
termination conditions for W outlined in step 3 are met.285
a: Estimate W(j) deterministically based on the current posterior dis-286
tribution f(Θ(j−1)|Y,W(j−1)), by setting w(j)ki = w(j)ik = 1 if the287
marginal 95% posterior credible intervals for (φ
(j−1)
k , φ
(j−1)
i ) over-288
lap and areas (k, i) share a common border. Otherwise, set w
(j)
ki =289
w
(j)
ik = 0.290
b: Estimate the posterior distribution f(Θ(j)|Y,W(j)) by fitting model291
(1)-(2) using INLA.292
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3: After j∗ iterations one of the following termination conditions will apply.293
Case 1 - The sequence of W estimates is such that W(j
∗) = W(j
∗+1),294
which is the estimated hyperparameter matrix Wˆ.295
Case 2 - The sequence of W estimates forms a cycle of m different296
states (W(j
∗),W(j
∗+1), . . . ,W(j
∗+m−1),W(j
∗+m)), where W(j
∗) =297
W(j
∗+m). In this case the estimated hyperparameter matrix Wˆ298
is the value from the cycle of m states that has the minimal level299
of residual spatial autocorrelation, as measured by the absolute300
value of Moran’s I statistic.301
When one of the termination conditions has been met Wˆ is the esti-302
mated spatial structure of the random effects, and Θ is summarised by303
the posterior distribution f(Θ|Y,Wˆ).304
The algorithm is initialized by assuming the random effects are indepen-305
dent so that initial spatial smoothness constraints are not imposed on the306
random effects. The update of W in step 2a assumes that if there is a sub-307
stantial difference between the current estimates of (φk, φi), that is their 95%308
credible intervals do not overlap, then they should be modelled as condition-309
ally independent, otherwise they are modelled as autocorrelated. In practice,310
the W estimates converge to a single value (Case 1) after a small number of311
iterations in almost all cases, and full details of the algorithm are given in312
Lee and Mitchell (2013).313
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4. Results314
This section presents the results of the study, including the model build-315
ing process, pollution-health relative risk estimates, and the impact of air316
pollution reductions on health.317
4.1. Model building318
We fit single disease and single pollutant models in this study, resulting319
in 20 different disease-pollutant combinations. Single disease models ensure320
that any cross correlations between the disease outcomes do not affect the321
estimated pollution-health relationships, while single pollutant models are322
used because of the high collinearity between the four pollutants (pairwise323
correlations range between 0.66 and 0.99) which hinders reliable joint estima-324
tion. To assess the robustness of our results to model choice we fit 2 different325
spatial autocorrelation models to the data, which are the Poisson log-linear326
Leroux CAR model ((1) and (2)), and the Poisson log-linear locally adaptive327
CAR model ((1) and (2) with the estimation of W as described in Section328
3.2).329
Each disease outcome is modelled by the expected numbers of disease330
events as an offset, one of the four pollutants, and a subset of the confounders331
outlined in Section 2, the latter including the dwellings per hectare variable332
and the 6 domain specific indicators of the SIMD. The main challenge with333
confounder selection is collinearity, because the education, employment and334
income domains all have high pairwise correlations above 0.86. Fitting mod-335
els with each of these variables separately shows that the income domain336
variable describes the most variation in the data, and thus is the one re-337
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tained with the other two being discarded. The remaining confounders do338
not exhibit this collinearity problem, and as they are all significantly related339
to most of the disease outcomes, they are retained in all models for con-340
sistency. Therefore, the set of confounders included in each model are the341
access to services, crime, housing and income domains of the SIMD, as well342
as the dwellings per hectare variable.343
The overall fits to the data of each model are presented in Table 2, which344
displays their Watanabe Akaike Information Criterion (WAIC, Watanabe,345
2010) value and the estimated effective number of independent parameters346
(p.w). The results presented relate to when PM2.5 was the pollutant included347
in the model, but the results for the other pollutants are almost identical and348
are not shown for brevity. The locally adaptive CAR model fits the two hos-349
pitalisation outcomes and total non-accidental mortality outcome better than350
the Leroux CAR model, with reductions in WAIC of 135 (cardiovascular),351
209 (respiratory) and 22 (mortality) respectively. These improvements in352
model fit are achieved despite the locally adaptive model having a smaller ef-353
fective number of independent parameters than the Leroux model. This phe-354
nomenon occurs because the random effects from the Leroux CAR model are355
globally spatially smooth, which hence forces smoothness between residual356
risks in geographically neighbouring IZs, even if those residual risks are very357
different. This inflates the random effects variance τ 2 because the residual358
risks are not spatially smooth, which results in a greater number of effective359
parameters. In contrast, the locally adaptive model does not smooth resid-360
ual risks in geographically adjacent IZs where those residual risks are very361
different, because it sets the corresponding wki = wik elements equal to zero362
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Table 2: Watanabe-Akaike Information Criterion (WAIC) and the effective number of
independent parameters from the Leroux and locally adaptive CAR models. For the
latter the number of {wki} elements estimated as zero is also presented.
Disease outcome Model WAIC p.w Number of {wki} set to zero
Cardiovascular hospitalisations Leroux 10,506 564 -
Adaptive 10,371 495 115 (3.5%)
Cardiovascular mortality Leroux 7,753 276 -
Adaptive 7,753 275 2 (0.1%)
Respiratory hospitalisations Leroux 10,706 616 -
Adaptive 10,497 522 386 (11.8%)
Respiratory mortality Leroux 6,874 244 -
Adaptive 6,871 251 0 (0%)
Total non-accidental mortality Leroux 9,782 528 -
Adaptive 9,760 489 150 (4.6%)
and thus does not assume any partial autocorrelations between the random363
effects in those IZs. To illustrate the locations of these step changes in the364
random effects surface, the locations of the borders for which wki = wik = 0365
are displayed for Edinburgh and Glasgow in Section 5 of the supplementary366
material.367
The largest number of {wki} elements estimated as zero is 386 (11.8%)368
for respiratory hospitalisations, while 115 (3.5%) and 150 (4.6%) were set369
to zero for cardiovascular hospitalisations and total non-accidental mortality370
respectively. In contrast, the two CAR models exhibit the same overall fit for371
the other two disease outcomes, which occurs because the locally adaptive372
model hardly estimates any wki = 0 and hence it simplifies to the Leroux373
CAR model.374
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4.2. Pollution-health effects375
The effects of each pollutant on each disease outcome estimated from376
the locally adaptive CAR model are presented in Table 3, while the corre-377
sponding effects for the non-pollutant covariates are presented in Section 3378
of the supplementary material accompanying this paper. For completeness,379
the pollution-disease effects estimated from the model with the Leroux CAR380
prior are displayed in Section 4 of the supplementary material, and show381
little change to those presented here, suggesting our results are robust to382
the choice of spatial autocorrelation model. Table 3 displays relative risks383
and 95% credible intervals for a 5µg m−3 increase in NO2 and NOx and a384
1µg m−3 increase in PM2.5 and PM10, because as discussed in Section 2.2,385
these are realistic increases for each of the pollutants.386
Table 3 shows that in this study air pollution only has a significant as-387
sociation with respiratory disease in our data. This is shown prominently388
for respiratory hospitalisations, where all four pollutants exhibit significant389
associations. For respiratory mortality the estimated associations are largely390
similar in size, and the lack of significance at the traditional 5% level (except391
for PM2.5) is because of the much wider credible intervals for this disease out-392
come, resulting from the much lower numbers of disease counts (less data)393
compared with respiratory hospitalisations. The effect sizes for respiratory394
hospitalisations range between a 1.4% and a 5.8% increased risk for the given395
pollutant increases, although given the differing levels of spatial variation in396
the pollutants these risks are not directly comparable. Cardiovascular disease397
and total non-accidental mortality appear to have no relationship with any398
of the four pollutants, because all 12 of the 95% credible intervals contain399
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Table 3: Estimated relative risks and 95% credible intervals for the pollution-disease effects
from the model with the locally adaptive CAR prior. The results for NO2 and NOx relate
to a 5µg m−3 increase whilst those for PM2.5 and PM10 relate to a 1µg m−3 increase. The
significant associations are shown in bold.
Disease outcome
Pollutant
NO2 NOx PM2.5 PM10
Cardiovascular hospitalisations 1.012 1.006 1.018 1.006
(0.994, 1.030) (0.995, 1.016) (0.997, 1.040) (0.995, 1.017)
Cardiovascular mortality 0.988 0.993 0.995 0.997
(0.970, 1.006) (0.982, 1.005) (0.994, 1.016) (0.987, 1.008)
Respiratory hospitalisations 1.028 1.014 1.058 1.023
(1.008, 1.048) (1.002, 1.025) (1.034, 1.083) (1.011, 1.035)
Respiratory mortality 1.032 1.017 1.045 1.014
(0.997, 1.067) (0.996, 1.038) (1.002, 1.090) (0.992, 1.035)
Total non-accidental mortality 1.003 1.001 1.012 1.005
(0.986, 1.020) (0.990, 1.011) (0.992, 1.033) (0.995, 1.016)
the null risk of one, and the estimated risks are mostly very close to one.400
4.3. Estimating the health impact of pollution reductions401
We now use the modelling results to quantify the health impact of re-402
ducing air pollution concentrations in each IZ within the four main Scottish403
cities, Aberdeen, Dundee, Edinburgh and Glasgow, which will illustrate the404
potential health impact of the planned LEZs. We do this by computing the405
expected reduction in the numbers of disease cases (hospital admissions or406
mortalities) in each IZ over 2015-2016 if average concentrations over that407
two-year period had reduced by ωµg m−3. We undertake this analysis for408
each pollutant and disease outcome separately because we have implemented409
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single pollutant and single disease models, and note that these estimated410
reductions should not be summed over pollutants or diseases as they are not411
independent. From equation (1) the estimated reduction in the expected412
number of disease events for the kth IZ, E[Yk], if pollutant xk reduced by413
ωµg m−3 is given by:414
Reductionk = E[Yk|xk]− E[Yk|xk − ω] (4)
= ek exp(z
>
k αˆ + xkβˆ + φˆk)− ek exp(z>k αˆ + (xk − ω)βˆ + φˆk)
= ek exp(z
>
k αˆ + xkβˆ + φˆk)[1− exp(−ωβˆ)]
= ekθˆk[1− exp(−ωβˆ)].
This reduction depends on the estimated air pollution and health effect415
βˆ, the pollution reduction ωµg m−3, the underlying size and demographics416
of the population at risk via ek, and the estimated level of disease risk via417
θˆk = exp(z
>
k αˆ + xkβˆ + φˆk). To understand the range of reductions that418
might be observed, Table 4 displays the estimated total reductions across419
the four cities resulting from the following pollutant reductions: NO2 / NOx420
- 2µg m−3, 5µg m−3 and 10µg m−3; and PM2.5 / PM10 - 0.5µg m−3, 1µg m−3421
and 3µg m−3. Here each city is defined by its local authority region, and the422
pollution-disease combinations listed in the table relate to the significant423
associations from Table 3.424
The table shows that the estimated reductions in disease cases scales with425
the chosen pollution reductions, as for example increasing the reduction of426
PM2.5 from 0.5µg m
−3 to 1µg m−3 in Edinburgh results in around 400 and427
800 fewer respiratory hospitalisations respectively. The biggest reductions428
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are in Glasgow because it has the largest population in Scotland, with an429
estimated reduction of 1,576 fewer admissions to hospital over the two year430
study period (an average of 788 per year) due to respiratory disease if PM2.5431
reduced by 1µg m−3. In contrast, Dundee, the smallest of the four cities,432
had an estimated reduction in admissions of 352 over the two-year period433
(on average 176 per year) for the same 1µg m−3 decrease in concentrations.434
Finally, as mortalities are much rarer than hospital admissions, the estimated435
reductions in respiratory mortalities are much smaller than the corresponding436
reductions for respiratory hospitalisations.437
Equation (4) shows that the health impact of a fixed ωµg m−3 reduction438
in a pollutant will vary by IZ, and thus where those reductions are highest439
would be where pollution reduction policies, such as an LEZ, would have the440
largest public health benefit. The left column of Figure 3 illustrates this, by441
displaying, for Edinburgh (top left) and Glasgow (top right), the estimated442
reductions in respiratory hospitalisations in each IZ between 2015-2016 that443
would have occurred if NO2 concentrations had been reduced by 5µg m
−3.444
The right column of the figure presents the estimated NO2 concentrations for445
the two cities, allowing us to spatially compare the locations with the high-446
est concentrations and the highest health impacts of reducing concentrations.447
We have chosen to display the results for NO2 because traffic related inter-448
ventions, such as the Glasgow LEZ, are designed to reduce this pollutant449
more than particulates. However, the same general pattern is observed for450
all 4 pollutants.451
The figure shows the same fundamental message for both cities, namely452
that reducing NO2 concentrations in a city centre where concentrations are453
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Table 4: Estimated reductions in the expected numbers of disease events in 2015-2016 in
Aberdeen, Dundee, Edinburgh and Glasgow if a pollutant decreased by ωµg m−3. The
values in brackets relate to the region containing the Glasgow LEZ.
Disease / Pollutant
City
Aberdeen Dundee Edinburgh Glasgow (LEZ)
Respiratory hospitalisations
NO2 - ω = 2 71 71 161 316 (5)
NO2 - ω = 5 176 175 398 784 (13)
NO2 - ω = 10 347 345 785 1547 (26)
NOx - ω = 2 35 35 80 158 (3)
NOx - ω = 5 88 88 199 393 (7)
NOx - ω = 10 175 175 395 781 (14)
PM2.5 - ω = 0.5 179 178 405 799 (14)
PM2.5 - ω = 1 354 352 798 1,576 (27)
PM2.5 - ω = 3 1005 999 2265 4474 (77)
PM10 - ω = 0.5 73 73 165 325 (6)
PM10 - ω = 1 144 143 325 641 (11)
PM10 - ω = 3 409 406 923 1820 (31)
Respiratory mortality
PM2.5 - ω = 0.5 12 10 22 39 (1)
PM2.5 - ω = 1 23 19 44 78 (1)
PM2.5 - ω = 3 66 55 126 224 (3)
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highest and hence where LEZs are typically located, will likely have a rel-454
atively low public health impact in terms of the number of cases. This is455
because city centres have comparatively low resident populations at risk due456
to being mainly commercial centres, resulting in smaller estimated reductions457
in the numbers of disease events. The same observation is true for Aberdeen458
and Dundee, and the results are displayed in Section 4 of the supplementary459
material.460
The location for the Glasgow LEZ is highlighted by the blue line in Fig-461
ure 3, and the bottom right panel shows it has some of the highest NO2462
concentrations in the city. However, the bottom left panel shows that the463
health impact from reducing the concentrations in the LEZ will likely be464
small, as the three IZs that make up the LEZ combined have a total reduc-465
tion of 13 hospital admissions over 2015-2016 (on average between 6 and 7 a466
year), less than 2% of the estimated reduction for the whole city. The cor-467
responding reductions in estimated disease events for the LEZ for the other468
pollutants, health outcomes, and sizes of pollutant reduction are shown in469
brackets in Table 4, and again show very small numbers compared with the470
city of Glasgow as a whole.471
5. Comparability of epidemiological air pollution studies472
Large numbers of epidemiological air pollution studies have been con-473
ducted across the world, which has led researchers and policy-makers to474
directly compare the results from multiple studies. However this is prob-475
lematic, because the estimated effect sizes will depend on both the strength476
of the pollution-health association and the amount of variation in pollution477
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Figure 3: Maps of the estimated reductions in respiratory hospitalisations in each IZ due
to a 5µg m−3 reduction in NO2 concentrations (left), and the average NO2 concentrations
(right). The top row refers to Edinburgh and the bottom row refers to Glasgow. The blue
line denotes the boundary of the proposed Glasgow LEZ.
27
concentrations across the study region. To see this note that from equation478
(1) the risk for area k is given by479
θˆk = exp(z
>
k αˆ + xkβˆ + φˆk), (5)
where the exposure xk has mean x¯ =
1
K
∑K
k=1 xk and variance σ
2
x =480
1
n−1
∑K
k=1(xk− x¯)2. Now consider a linearly scaled exposure vk = (1+ψ)xk−481
ψx¯, where it is straightforward to show that they have the same mean (i.e.482
v¯ = x¯) and the variances are related by σ2v = (ψ + 1)
2σ2x. Then replacing xk483
by vk in equation (1) yields:484
θˆk = exp(z
>
k αˆ
∗ + vkβˆ∗ + φˆ∗k) (6)
= exp(z>k αˆ∗ + [(1 + ψ)xk − ψx¯]βˆ∗ + φˆ∗k)
= exp(z>k αˆ∗ + xk(1 + ψ)βˆ∗ − ψx¯βˆ∗ + φˆ∗k).
Comparing (5) and (6) shows that the coefficients for the scaled and un-485
scaled exposures (vk, xk) are related by βˆ∗ =
βˆ
1+ψ
. Therefore, comparing486
estimated effect sizes between studies with different levels of exposure vari-487
ation is not appropriate, because the level of exposure variation affects the488
estimated regression coefficient. This explains the large estimated effect sizes489
for PM2.5 on respiratory disease outcomes observed in this study, because the490
level of variation in the 2-year average PM2.5 concentrations across Scotland491
is very low (the standard deviation is only 0.81µg m−3).492
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6. Discussion493
This paper has presented a new study of the health impact of long-term494
exposure to air pollution in Scotland using a spatial small-area design, and495
has used the results to quantify the likely health impact of air pollution re-496
duction interventions such as Low Emission Zones. Our first main finding is497
that the four pollutants considered here exhibit associations with respiratory498
disease (hospitalisations and mortality), even though for mortality three of499
the relative risks are not significant at the 5% level as a result of small num-500
bers of deaths leading to wide credible intervals. In contrast, no significant501
associations were observed for cardiovascular disease or total non-accidental502
mortality, with all relative risks being non-significant and close to one in503
magnitude (ranging between 0.988 and 1.018). No significant associations504
between cardiovascular disease and air pollution were also found by Willocks505
et al. (2012) in Scotland and Carey et al. (2013) and Dehbi et al. (2017) in506
Great Britain using time series and cohort methodologies respectively, which507
means our findings are consistent with previous studies on British popula-508
tions.509
Our second main finding is that focusing an air pollution reduction inter-510
vention, such as an LEZ, on a city centre where concentrations are highest is511
likely to have a relatively small positive health impact at the national level,512
because these areas are largely commercial and hence have small resident513
populations. Even though these areas will routinely see large numbers of514
people visiting for both shopping and working, their time spent in the area,515
especially outdoors, will likely be relatively short. The evidence presented516
here therefore suggests that the LEZ planned for Glasgow may have a rela-517
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tively small positive net health benefit. We note however that our study has518
not evaluated the effect of the Glasgow LEZ directly, because the pollution519
reductions from the LEZ are not known as it will not be fully operational520
until the end of 2022. However, other studies have directly evaluated the521
impact of LEZs across Europe, including studies in Amsterdam (Panteliadis522
et al., 2014) and Munich (Fensterer et al., 2014) where the LEZ appeared to523
reduce concentrations, and in the UK (London and Birmingham, Jones et al.,524
2012; Wood et al., 2015) where it did not appear to reduce concentrations.525
A thorough review of LEZs is beyond the scope of this paper, and the reader526
is referred to Holman et al. (2015) and AIRUSE (2016).527
The choice of where one should locate an air pollution intervention, such528
as an LEZ, depends on the ultimate goal. If the main aim is to reduce529
the number of preventable disease cases attributable to air pollution, then530
Figure 3 suggests that an intervention should be targeted at areas that have531
both relatively high pollutant concentrations and a relatively large and more532
vulnerable population. In contrast, if compliance with air quality limits is the533
key requirement, such as reducing pollution concentrations below European534
Union limits (European Parliament, 2008), then interventions need only be535
targeted at areas with the highest concentrations that are not in compliance.536
Finally, if the aim is an overall reduction in the risk of air pollution, then more537
geographically wide-reaching air pollution reduction policies are needed.538
The main limitation of our work (shared by all other epidemiological air539
pollution studies) in respect of attempting to predict the potential health im-540
pacts of LEZs is the use of ambient residential concentrations as a proxy for541
personal exposures, which ignores peoples movements such as daily commut-542
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ing patterns. In future work we will combine the methodology developed here543
with population movement models, to identify the possible health impacts544
of reducing air pollution in city centres on personal exposures. Additionally,545
we will consider the impact of an LEZ on air pollution concentrations in the546
rest of the city, which are likely to occur because an LEZ will require cleaner547
buses that will service routes that travel out-with the LEZ area.548
A second limitation with this study is that the pollution data are assumed549
to be true and measured without error, where as in fact they come from the550
atmospheric PCM model and thus are subject to error and uncertainty. Nu-551
merous solutions have been proposed to allow for pollution uncertainty in552
disease models, and a recent example using fusion modelling (Berrocal et al.,553
2010) is provided by Blangiardo et al. (2016). A further limitation is the554
ecological nature of this small-area study, which in common with time series555
studies (e.g. Dominici et al., 2004), uses population-level disease summaries556
rather than individual-level data. This means that only group level associ-557
ations rather than individual-level cause and effect can be estimated, which558
provides a weaker evidence base. However, individual-level disease data are559
not available for confidentiality purposes, and population-level small-area560
studies are commonplace and are critiqued by Wakefield (2007).561
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